172 related articles for article (PubMed ID: 35372573)
1. Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma.
Xiang J; Chen X; Chen M; Hou J
Biomed Res Int; 2022; 2022():3307873. PubMed ID: 35372573
[TBL] [Abstract][Full Text] [Related]
2. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic localization of SETDB1‑induced Warburg effect via c‑MYC‑LDHA axis enhances migration and invasion in breast carcinoma.
Yang W; Wei Y; Wang T; Xu Y; Jin X; Qian H; Yang S; He S
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426579
[TBL] [Abstract][Full Text] [Related]
4. SETDB1 promotes progression through upregulation of SF3B4 expression and regulates the immunity in ovarian cancer.
Yang H; Sui L; Cai C; Chu H; Diao Y
J Ovarian Res; 2024 Feb; 17(1):34. PubMed ID: 38317200
[TBL] [Abstract][Full Text] [Related]
5. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation.
Qian X; Yang Y; Deng Y; Liu Y; Zhou Y; Han F; Xu Y; Yuan H
Exp Ther Med; 2023 Jun; 25(6):274. PubMed ID: 37206551
[TBL] [Abstract][Full Text] [Related]
6. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
[TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
9. High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma.
Chen X; Li X; Wei C; Zhao C; Wang S; Gao J
Transl Cancer Res; 2021 Dec; 10(12):5065-5075. PubMed ID: 35116358
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase SET domain bifurcated 1 negatively regulates parathyroid hormone/parathyroid hormone-related peptide receptor to control chondrocyte proliferation in Meckel's cartilage.
Thiha P; Higashihori N; Kano S; Moriyama K
Arch Oral Biol; 2021 Nov; 131():105251. PubMed ID: 34521010
[TBL] [Abstract][Full Text] [Related]
11. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
12. SETDB1: A perspective into immune cell function and cancer immunotherapy.
Johnson E; Salari K; Yang S
Immunology; 2023 May; 169(1):3-12. PubMed ID: 36524435
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma.
Fu L; Cheng Z; Dong F; Quan L; Cui L; Liu Y; Zeng T; Huang W; Chen J; Pang Y; Ye X; Wu G; Qian T; Chen Y; Si C
J Cancer; 2020; 11(5):1182-1194. PubMed ID: 31956364
[No Abstract] [Full Text] [Related]
14. Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma.
Ho YJ; Lin YM; Huang YC; Chang J; Yeh KT; Lin LI; Gong Z; Tzeng TY; Lu JW
APMIS; 2017 Nov; 125(11):985-995. PubMed ID: 28913972
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
16. Preparation of the ubiquitination-triggered active form of SETDB1 in Escherichia coli for biochemical and structural analyses.
Funyu T; Kanemaru Y; Onoda H; Arita K
J Biochem; 2021 Dec; 170(5):655-662. PubMed ID: 34324684
[TBL] [Abstract][Full Text] [Related]
17. SETDB1 Triple Tudor Domain Ligand, (
Uguen M; Deng Y; Li F; Shell DJ; Norris-Drouin JL; Stashko MA; Ackloo S; Arrowsmith CH; James LI; Liu P; Pearce KH; Frye SV
ACS Chem Biol; 2023 Aug; 18(8):1846-1853. PubMed ID: 37556795
[TBL] [Abstract][Full Text] [Related]
18. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
[TBL] [Abstract][Full Text] [Related]
19. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
